Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60

被引：0
|
作者：
Foong, Yi Chao [1 ]
Merlo, Daniel [2 ]
Gresle, Melissa [2 ]
Zhu, Chao [2 ]
Buzzard, Katherine [2 ]
Zhong, Michael [1 ]
Yeh, Wei [1 ]
Jokubaitis, Vilija [1 ]
Butzkueven, Helmut [1 ]
van der Walt, Anneke [1 ]
机构：
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Clayton, Vic, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 04期
关键词：
ocrelizumab; multiple sclerosis; elderly; comparative efficacy; MSBase;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [21] Glatiramer acetate or interferon-P for multiple sclerosis? A guide to drug choice
    Milo, R
    Panitch, H
    CNS DRUGS, 1999, 11 (04) : 289 - 306
  • [22] Factors related with treatment adherence to interferon β and glatiramer acetate therapy in multiple sclerosis
    Río, L
    Porcel, J
    Téllez, N
    Sánchez-Betancourt, A
    Tintoré, M
    Arévalo, MJ
    Nos, C
    Montalban, X
    MULTIPLE SCLEROSIS, 2005, 11 (03): : 306 - 309
  • [23] Putative mechanisms of action of statins in multiple sclerosis -: comparison to interferon-β and glatiramer acetate
    Neuhaus, O
    Stüve, O
    Archelos, JJ
    Hartung, HP
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 233 (1-2) : 173 - 177
  • [24] Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis
    Kerstin Hellwig
    Ralf Gold
    Journal of Neurology, 2011, 258 : 502 - 503
  • [25] Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Di Pietrantonj, Carlo
    Rovaris, Marco
    Rigon, Giulio
    Frau, Serena
    Berardo, Francesco
    Gandini, Anna
    Longobardi, Anna
    Weinstock-Guttman, Bianca
    Vaona, Alberto
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (09): : 1016 - 1020
  • [26] Effects of glatiramer acetate and interferon-β on neurodegeneration in a model of multiple sclerosis -: A comparative study
    Maier, Katharina
    Kuhnert, Antje V.
    Taheri, Naimeh
    Saettler, Muriel B.
    Storch, Maria K.
    Williams, Sarah K.
    Baehr, Mathias
    Diem, Ricarda
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (04): : 1353 - 1364
  • [27] Neurometabolic changes in multiple sclerosis: Fingolimod versus beta interferon or glatiramer acetate therapy
    Al-iedani, Oun
    Lea, Rodney
    Ribbons, Karen
    Ramadan, Saadallah
    Lechner-Scott, Jeannette
    JOURNAL OF NEUROIMAGING, 2022, 32 (06) : 1109 - 1120
  • [28] Potential biomarkers of clinical response to interferon-beta and glatiramer acetate in multiple sclerosis
    Dhib-Jalbut, S
    MULTIPLE SCLEROSIS, 2005, 11 : S11 - S11
  • [29] Mitoxantrone in secondary progressive multiple sclerosis: after or with interferon-beta or glatiramer acetate
    Akman-Demir, G
    Aydin, Z
    Eraksoy, M
    JOURNAL OF NEUROLOGY, 2004, 251 : 123 - 123
  • [30] Interferon beta and glatiramer acetate decrease oxidative activity of leukocytes in patients with multiple sclerosis
    de Riso, S.
    Angeleri, V.
    Bacchetti, T.
    Danni, M.
    Ferretti, G.
    Viti, B.
    Provinciali, L.
    MULTIPLE SCLEROSIS, 2007, 13 : S66 - S66
12345